Orphazyme down to 20 employees after multiple firing rounds

The negative events of the past year involving Orphazyme have not just made their mark on the biotech company’s finances, but also on its number of staff.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Orphazyme confirms delisting in the US
For subscribers
Orphazyme's creditors left without real options
For subscribers